{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:55:21Z","timestamp":1794099321155,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.rpth.2024.102354","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T01:05:13Z","timestamp":1707959113000},"page":"102354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Drug-related problems associated with direct oral anticoagulants: an observational cross-sectional study of medical record review by pharmacists in a large teaching hospital"],"prefix":"10.1016","volume":"8","author":[{"given":"Melissa M.Y.","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duke J.J.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian S.Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Y.","family":"How","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei K.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Y.","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102354_bib1","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/bcp.13234","article-title":"Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions","volume":"83","author":"Monaco","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rpth.2024.102354_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.amjmed.2004.09.018","article-title":"The incidence of adverse drug events in two large academic long-term care facilities","volume":"118","author":"Gurwitz","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2024.102354_bib3","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.amjmed.2016.06.003","article-title":"Bleeding with direct oral anticoagulants vs warfarin: clinical experience","volume":"129","author":"Eikelboom","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2024.102354_bib4","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11096-015-0106-3","article-title":"Pharmacists\u2019 role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies","volume":"37","author":"Desmaele","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.rpth.2024.102354_bib5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11096-010-9377-x","article-title":"Classification of drug-related problems with new prescriptions using a modified PCNE classification system","volume":"32","author":"Eichenberger","year":"2010","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.rpth.2024.102354_bib6","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.rpth.2024.102354_bib7","first-page":"555","article-title":"Direct oral anticoagulants in real clinical practice: analysis of patient characteristics and prescribing patterns in a large teaching hospital","volume":"72","author":"Kov\u00e1\u010dov\u00e1","year":"2017","journal-title":"Pharmazie"},{"key":"10.1016\/j.rpth.2024.102354_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11239-018-1752-9","article-title":"Direct oral anticoagulants: a review of common medication errors","volume":"47","author":"Barr","year":"2019","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2024.102354_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1086-5802(16)31229-3","article-title":"Drug-related morbidity and mortality: updating the cost-of-illness model","volume":"41","author":"Ernst","year":"2001","journal-title":"J\u00a0Am Pharm Assoc (Wash)"},{"key":"10.1016\/j.rpth.2024.102354_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1185\/03007995.2015.1131676","article-title":"An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants","volume":"32","author":"Deitelzweig","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rpth.2024.102354_bib11","first-page":"245","article-title":"Pharmacist interventions regarding the appropriateness of apixaban, rivaroxaban, dabigatran, and warfarin in a university-affiliated outpatient clinic","volume":"32","author":"Phillippe","year":"2016","journal-title":"J\u00a0Pharm Technol"},{"key":"10.1016\/j.rpth.2024.102354_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41598-020-80560-2","article-title":"Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions","volume":"11","author":"Garin","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2024.102354_bib13","author":"Stevenson"},{"key":"10.1016\/j.rpth.2024.102354_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4097\/kjae.2013.64.5.402","article-title":"The prevention and handling of the missing data","volume":"64","author":"Kang","year":"2013","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.rpth.2024.102354_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jcpt.12473","article-title":"Prevalence of drug-related problems associated with direct oral anticoagulants in hospitalized patients: a multicenter, cross-sectional study","volume":"42","author":"Viprey","year":"2017","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.rpth.2024.102354_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/10742484211019657","article-title":"Prescribing errors with direct oral anticoagulants and their impact on the risk of bleeding in patients with atrial fibrillation","volume":"26","author":"Raccah","year":"2021","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.rpth.2024.102354_bib17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00228-021-03212-y","article-title":"Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis","volume":"78","author":"Al Rowily","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rpth.2024.102354_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11096-020-00970-0","article-title":"Physicians\u2019 acceptance of pharmacists\u2019 interventions in daily hospital practice","volume":"42","author":"Zaal","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.rpth.2024.102354_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1365-2753.2011.01704.x","article-title":"Computerized physician order entry system combined with on-ward pharmacist: analysis of pharmacists\u2019 interventions","volume":"18","author":"Bedouch","year":"2012","journal-title":"J\u00a0Eval Clin Pract"},{"key":"10.1016\/j.rpth.2024.102354_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11096-013-9798-4","article-title":"Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts","volume":"35","author":"Zaal","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.rpth.2024.102354_bib21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102354_bib22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102354_bib23","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102354_bib24","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102354_bib25","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of\u00a0acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102354_bib26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102354_bib27","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1681\/ASN.2016090980","article-title":"Apixaban pharmacokinetics at steady state in hemodialysis patients","volume":"28","author":"Mavrakanas","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2024.102354_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37288","article-title":"Clinician trends in prescribing direct oral anticoagulants for US medicare beneficiaries","volume":"4","author":"Wheelock","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rpth.2024.102354_bib29","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s11096-020-00976-8","article-title":"Prevalence and risk factors of drug-related problems identified in pharmacy-based medication reviews","volume":"42","author":"Sell","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.rpth.2024.102354_bib30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11239-020-02326-x","article-title":"Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribing","volume":"52","author":"Kampouraki","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2024.102354_bib31","doi-asserted-by":"crossref","first-page":"f329","DOI":"10.1093\/europace\/eux322","article-title":"Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort","volume":"20","author":"Jani","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.rpth.2024.102354_bib32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1177\/1060028021995201","article-title":"The impact of body weight and renal function on the risk of bleeding with direct oral anticoagulants in atrial fibrillation","volume":"55","author":"Whittemore","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rpth.2024.102354_bib33","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.2021.21222","article-title":"Association of rivaroxaban vs apixaban with major ischemic or hemorrhagic events in patients with atrial fibrillation","volume":"326","author":"Ray","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2024.102354_bib34","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.3390\/ijerph19116724","article-title":"The effectiveness of interventions to evaluate and reduce healthcare costs of potentially inappropriate prescriptions among the older adults: a systematic review","volume":"19","author":"Mucherino","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.rpth.2024.102354_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2019.07.026","article-title":"Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding","volume":"182","author":"Xu","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102354_bib36","first-page":"1693","article-title":"Medications errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases","volume":"35","author":"Al Rowily","year":"2022","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.rpth.2024.102354_bib37","article-title":"Anticoagulation stewardship: descriptive analysis of a novel approach to appropriate anticoagulant prescription","volume":"6","author":"Koolian","year":"2022","journal-title":"Res Pratt Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102354_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270263","article-title":"Drug-related problem characterization and the solved status associated factor analysis in a pharmacist-managed anticoagulation clinic","volume":"17","author":"Wung","year":"2022","journal-title":"Plos One"},{"key":"10.1016\/j.rpth.2024.102354_bib39","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s11096-021-01302-6","article-title":"Direct oral anticoagulant-related medication incidents and pharmacists\u2019 interventions in hospital in-patients: evaluation using reason\u2019s accident causation theory","volume":"43","author":"Haque","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.rpth.2024.102354_bib40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11096-023-01555-3","article-title":"Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists\u2019 views and experiences","volume":"45","author":"Al Rowily","year":"2023","journal-title":"Int J Clin Pharm"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:28:31Z","timestamp":1762864111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2475037924000438"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102354","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-related problems associated with direct oral anticoagulants: an observational cross-sectional study of medical record review by pharmacists in a large teaching hospital","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102354"}}